GLP-1 injections and oral treatments with ongoing clinical support
Hormone replacement therapy with specialist support
At-home kits matched by questionnaire, with clinician-reviewed results in your account
Effective prescription treatments - prescribed same day
Clinically proven treatments that work for 9 in 10 men
Prescription treatments for acne, rosacea and more
Prescription support to help you quit for good
Repeat contraceptive pill prescriptions reviewed by UK clinicians
Short-term norethisterone prescriptions for delaying your period
Prescription migraine relief when over-the-counter options are not enough
Confidential at-home STI testing with fast results from our UK lab
Discreet at-home sexual health screening with UK clinician support
Prescription-strength antihistamines and nasal sprays for seasonal allergies
Discreet consultations for prescription PE treatments
Clinician-reviewed supplement plans alongside your treatment
If you are eating well and moving more, yet the scale barely shifts, the problem is often biology rather than willpower. Hormones, thyroid function, blood sugar, and iron stores all influence how readily your body loses fat.
PrivateDoc can look at those markers with a home Weight and Metabolism blood test, then assess whether prescription options such as Wegovy, Mounjaro, or a daily tablet such as Foundayo are appropriate after a full consultation.
Weight management is heavily influenced by hormones and metabolic rate. An underactive thyroid (hypothyroidism) or insulin resistance can make your body store fat more readily and burn calories more slowly. Low iron causes fatigue that looks like a slow metabolism. Without those markers, you can keep tightening the plan and still see little change.
That is also why some people regain after stopping GLP-1 treatment. Appetite hormones return while resting energy burn stays lower. See why weight returns after weight-loss medication and our maintenance plans.
The full walkthrough lives in our home blood test guide. You collect a finger-prick sample and a clinician reviews the laboratory report in your account.
If markers point to a metabolic barrier, clinicians can recommend lifestyle changes, GP follow-up, or a prescription pathway. Typical UK eligibility for medicines such as Wegovy and Mounjaro is a BMI of 30 kg/m², or 27 kg/m² with a weight-related condition. Photos and ID still apply. Read how to get a weight-loss prescription online in the UK.
A blood test does not guarantee a prescription. Treatment is only authorised after a successful clinical assessment.
If you want medically supervised weight loss, start a consultation. If you first want to understand your metabolism, take the blood-test questionnaire.
Disclaimer: This article is for general information only and does not replace personalised medical advice. Treatment is only authorised after a successful clinical assessment.
Often no. Thyroid function, insulin resistance, and low iron can stall progress even when diet and activity are consistent. A clinician-reviewed blood test can show whether biology is in the way.
It can help when progress has stalled or tiredness is unexplained. It is not a substitute for the prescribing consultation. Your clinician decides whether a panel adds value.
The Weight and Metabolism profile is the usual starting point. It checks TSH, Free Thyroxine, HbA1c, lipids, and ferritin. See the home blood test article for the full marker list.
We'll provide you with a tailored treatment plan from a UK registered doctor
Receive genuine medication shipped discreetly to your door
Yes, through a CQC-registered clinic with GMC or ANP review and a GPhC pharmacy. See BMI rules, contraindications, photos, delivery, and maintenance after you hit target weight.
A 2026 checklist for buying Wegovy, Mounjaro, or oral GLP-1s online in the UK: CQC and GPhC badges, ID and photos, named prescribers, and how PrivateDoc's pathway works.
How daily Foundayo and the Wegovy pill compare with weekly Mounjaro and Wegovy pens, plus when Mysimba still fits. Storage, needles, fasting rules, and who suits tablets.
How PrivateDoc titrate-down and maintain packages work, why injections stay on a weekly schedule, and how a 12-month restart window protects results after GLP-1 treatment.
CQC and GPhC remote-prescribing rules explain weight photos, ID checks, GP letters, video consults, and the 30-second clip option if an image is unclear.
How to switch from Wegovy to Mounjaro in the UK: why patients change, BMI rules, PrivateDoc dose mapping, 7- or 14-day gaps, and what to expect during the transition.
How daily GLP-1 pills such as Foundayo and the Wegovy pill fit 2026 UK maintenance plans, how they compare with Mysimba and Orlistat, and how clinician-led care helps keep weight off.
How to choose a UK online clinic for oral weight loss care: Foundayo, the Wegovy pill, Mysimba and Orlistat, CQC and GPhC checks, eligibility, and how PrivateDoc prescribes safely.
How PrivateDoc weight-loss maintenance plans work: titrate-down or steady-dose packages, the 12-month restart policy, and practical habits to keep results after you reach goal weight.
Why PrivateDoc verifies weight before prescribing GLP-1 treatment: CQC and GPhC safety, photo cadence, what happens if an image is unclear, and how to send a short verification video.
Why weight often returns after GLP-1 treatment: food noise, metabolic slowdown, muscle loss, and how PrivateDoc tapering, protein, and maintenance plans reduce regain risk.
What's new in 2026 for oral vs injectable weight loss treatments? Compare Foundayo, the Wegovy pill, Mounjaro and Wegovy pens, and how PrivateDoc helps you choose or switch.
Can you switch from Mounjaro to Foundayo in the UK? How results compare, how doses are mapped, side effects to expect, and how PrivateDoc clinicians manage a safe transition.
The MHRA approved Foundayo (orforglipron) in August 2026. How the once-daily GLP-1 tablet compares with Wegovy and Mounjaro, who may be eligible, and how to check your eligibility with PrivateDoc.
A simple guide to weight loss medication in 2026: oral vs injectable GLP-1 treatments, what's new in UK prescribing, how options compare, and what the future of medical weight management looks like.
How oral weight loss treatment supports long term results: medication with lifestyle change, medically supervised GLP-1 tablets, safe UK prescribing, and ongoing support with PrivateDoc.
How oral weight loss treatments support adults: medically supervised GLP-1 tablets, appetite mechanisms, supervised care, medication-assisted weight loss, and building lasting habits with PrivateDoc.
How to build a UK medical weight loss plan online: remote consultations, clinician-led prescribing, sustainable support, and how to compare safe prescription weight loss services with PrivateDoc.
How oral weight loss drugs fit UK daily life: morning routines, GLP-1 tablets, safe prescribing, ongoing clinical support, and choosing evidence-based weight management with PrivateDoc.
Compare oral weight loss tablets and weekly injections for daily life: dosing, storage, evidence, adherence, and how PrivateDoc helps you choose the right GLP-1 format.
How to switch safely from Mounjaro or Wegovy injections to the daily Wegovy pill: dose mapping, washout gaps, side-effect guidance, and PrivateDoc clinical review.
Stay on the Wegovy pill long term: side effects, daily routine, cravings, diet, when to contact your prescriber, and check your eligibility through PrivateDoc.
How to choose safe oral weight loss services in the UK: CQC and GPhC checks, MHRA-licensed Wegovy pill, clinician review, red flags, and via PrivateDoc.
What oral weight loss medication is in the UK: the MHRA-licensed Wegovy pill, how it works, eligibility, side effects, and how to check your eligibility through PrivateDoc.
How oral GLP-1 weight loss pills reduce appetite: hormone science, food noise, side effects, and accessing the MHRA-licensed Wegovy pill in the UK.
Oral GLP-1 weight loss pills in the UK after MHRA licensing of the Wegovy pill on 11 June 2026: eligibility, monitoring, and how to check your eligibility.
Compare oral weight loss pills and GLP-1 injections in the UK: effectiveness, adherence, side effects, and accessing the MHRA-licensed Wegovy pill.
The next generation of UK weight loss medications: once-daily pills, MHRA licensing of the Wegovy pill, and how to check your eligibility through PrivateDoc.
Compare Wegovy injection and the Wegovy pill: dosing, routine, storage, STEP vs OASIS trial results, and MHRA UK licensing on 11 June 2026.
Is the Wegovy pill as effective as injections? Compare oral and injectable semaglutide weight-loss results, side effects, and get the Wegovy pill.
Reflections from ECO / EASO 2026: how amylin-based therapies and CagriSema (cagrilintide–semaglutide) fit next to GLP-1 treatment, what trials suggest, and how structured obesity care is evolving.
After ECO 2026 and STEP UP, Wegovy 7.2 mg closes the headline gap with Mounjaro. Dr Ruch Karunadasa on efficacy, early responders, safety, and why personalised care—not brand rivalry—should drive decisions.
ECO 2026 analysis of STEP UP early responders: up to 27.7% weight loss on Wegovy 7.2 mg for some patients, with Dr Ruch Karunadasa on what the headline means—and what it does not.
Our Doctors have put together a useful guide to tell you everything you need to know about the new weight loss drug Wegovy.
Are Wegovy, Mounjaro and GLP-1 injections safe? MHRA licensing, prescriber checks, common side effects, and how to avoid unregulated suppliers in the UK.
For many of us, the journey to a healthier weight often starts with a number on a weighing scale. We step on it with anticipation, hoping to see a lower figure, and our mood can often be dictated by what it shows. But what if we told you that true, healthy weight loss is about so much more than just pounds and kilograms?
Build a realistic activity plan when starting weight loss treatment — weekly targets, low-impact options, and fitting movement around GLP-1 side effects.
Does Wegovy work? Clinical trial averages, realistic timelines, who responds best, and what lifestyle support improves outcomes on semaglutide in the UK.
Choosing a diet that works long term? Practical tips for effective eating on or off GLP-1 treatment — protein, portions, and habits that stick.
How to achieve long-term weight loss and maintain it.
New SURPASS-CVOT results reveal Mounjaro may reduce cardiovascular risk, improve survival, and enhance diabetes care
If you're currently prescribed Mounjaro (tirzepatide) for weight management, we want to make you aware of an important update about its cost.
Worried about the Mounjaro price rise? Find out how to switch to Wegovy, what to expect, and which weight loss drug is right for you
Find support from our team, ask for advice from like-minded people and join live sessions with PrivateDoc.
Find support from our team, ask for advice from like-minded people and join live sessions with PrivateDoc.
Unboxing your Mysimba treatment: what's in the pack, how to take tablets, titration schedule, and what to expect in your first weeks.
Paused Wegovy, Mounjaro, Wegovy Pill or Nevolat? Restart safely with dose guides, diet support, and clinical review — not where you left off.
Nevolat, the UK's new generic Saxenda alternative, offers a cost-effective weight loss solution. Explore how it compares to weekly GLP-1 injections, its effectiveness, and what makes it different.
Overview of newer UK weight loss medicines — GLP-1 injectables, oral options, and emerging treatments patients and prescribers are watching.
Recycle your used Saxenda and Wegovy pens with PenCycle, Novo Nordisk's free recycling program for pre-filled medical pens. Help reduce medical plastic waste and support a more sustainable future.
Unboxing your Saxenda starter pack: what's included, how to use the pen, first doses, and what to expect when beginning liraglutide treatment.
Find support from our team, ask for advice from like-minded people and join live sessions with PrivateDoc.
Unboxing your Saxenda medication: pen setup, injection technique, storage tips, and what to expect in your first weeks of treatment.
Losing even small amounts of weight has numerous health benefits, particulary in those with an obese BMI. Discover 6 weight loss benefits.
Dr Ruch Karunadasa MBBS Bsc MRCGP, Chief Medical Director at PrivateDoc, discusses the importance of the right support when on a weight loss journey and how PrivateDoc's service can support patients who want to lose weight.
What appetite suppressants are, how GLP-1 medicines help you feel full, and why hunger signals persist even when you're eating less..
So you've decided it's time to start your weight loss journey? Good for you! These hints and tips will help you get your weight loss journey off to the best start possible. It won't be easy, but it will be worth it.
Find support from our team, ask for advice from like-minded people and join live sessions with PrivateDoc.
How PrivateDoc's UK weight loss service works: online consultation, prescriber review, licensed treatments, discreet delivery, and ongoing support. We have treated 1000s of patients in the UK and helped them reach their weight loss goals, creating healthier and happier lives in the process.
Common side effects of Wegovy, Mounjaro, Wegovy Pill and Nevolat: nausea, constipation, how titration helps, when to seek help, and UK clinician tips.
Thinking of switching from Mounjaro to Wegovy? Our guide explains the process, what to expect, and the support you'll receive from PrivateDoc.
So you've decided it's time to start your weight loss journey? Good for you! These hints and tips will help you get your weight loss journey off to the best start possible. It won't be easy, but it will be worth it.
So you've decided it's time to start your weight loss journey? Good for you! These hints and tips will help you get your weight loss journey off to the best start possible. It won't be easy, but it will be worth it.
What tirzepatide is, how it powers Mounjaro, weight-loss evidence, UK licensing, and how dual-action GLP-1/GIP differs from semaglutide.
Wegovy is MHRA-approved for obesity in the UK. Learn how semaglutide works, who qualifies, dosing, side effects, and realistic weight-loss expectations.
Not seeing results? Don't quit just yet! Follow these tips for what to do if you're not seeing results from your prescription weight loss treatment.
Mounjaro diet UK: what to eat and avoid, nausea-friendly foods, alcohol guidance, vegan tips, and meal planning to support tirzepatide weight loss.
Mounjaro diet UK: what to eat and avoid, nausea-friendly foods, alcohol guidance, vegan tips, and meal planning to support tirzepatide weight loss.
Wegovy received MHRA approval in 2021. Current UK availability, NHS vs private access, supply updates, and how patients can start treatment today.
Worried about regaining weight after treatment? UK guidance on maintenance habits, dose tapering, and long-term support to keep results.
Reached your goal on Wegovy, Mounjaro, Wegovy Pill or Nevolat? Maintenance plans, lower doses, tapering, and lifestyle support to keep weight off.
What is Mounjaro and when is it available in the UK? Compare Mounjaro (Tirzepatide) to Wegovy, Mysimba and Saxenda for weight loss
With yo-yo diets becoming increasingly popular at this time of year, we explore the risks associated with yo-yo dieting and why we always promote sustainable, healthy weight loss goals.
When considering weight loss medication options, Wegovy (active ingredient Semaglutide) and Mounjaro (active ingredient Tirzepatide) stand out for their innovative approaches, but which is right for you?
Thinking of switching from Mounjaro to Wegovy? Our guide explains the process, what to expect, and the support you'll receive from PrivateDoc.
A groundbreaking treatment is making waves in the UK, offering new solution options for individuals with type 2 diabetes and obesity aiming for substantial weight reduction.
Explore the complete Mounjaro (tirzepatide) dosing schedule: typical four-week steps from 2.5 mg up to 15 mg weekly maintenance when clinically appropriate in the UK.
An evidence-based overview of how higher-dose Wegovy 7.2 mg (semaglutide) may influence type 2 diabetes control, cardiovascular outcomes, kidney function and overall metabolic health, based on current clinical trial and real-world data.
A clinically balanced overview of what typically happens when stopping Wegovy 7.2mg, including tapering options and considerations for long‑term weight management.
Learn how Wegovy (Semaglutide) dose escalation works, why gradual titration matters, the current dosing schedule, potential side effects, and what higher doses mean for patients with PrivateDoc guidance.
Wegovy 7.2mg, the highest licensed Semaglutide dose, may help patients who've plateaued on 2.4mg. Learn how it works, clinical results, safety considerations, and what to expect in the UK with PrivateDoc guidance.
Explore the latest developments in weight management for 2026, including the Wegovy® oral pill, 7.2mg Wegovy injections, and emerging GLP-1 and triple-agonist therapies.
The FDA has approved oral semaglutide 25mg (Wegovy® pill) for weight loss. Learn about the OASIS-4 trial results, benefits, and what comes next.
Discover what causes "Ozempic face" during weight loss with Wegovy or Mounjaro, and learn how to keep your skin healthy and supported throughout your journey.
Discover how the new 7.2 mg Wegovy dose compares with high-dose GLP-1 drugs like Mounjaro, Retatrutide and CagriSema, including efficacy, safety and future treatments.
Progress slower on Wegovy or Mounjaro? Nine reasons GLP-1 results stall — dosing, diet, sleep, and when to ask your prescriber for a review.
What the STEP UP trial reveals about Wegovy 7.2mg: weight-loss averages, responder rates, and what higher-dose semaglutide means for UK patients.
Compare Retatrutide and Mounjaro, including triple-action vs dual-action effects, current trial results, expected availability, and safety considerations.
BMI thresholds for Wegovy, Mounjaro, Wegovy Pill and UK weight loss injections: 30+ or 27+ with comorbidities, ethnic adjustments, and prescriber checks.
Explore the complete Wegovy dosing schedule: stepwise weekly doses from 0.25 mg up to 2.4 mg standard maintenance and 7.2 mg where clinically appropriate in the UK.
At a time in which the obesity epidemic continues to explode across the world, many pharmaceutical companies and health care professionals have been working diligently to discover the most effective medical treatments to help patients manage their weight.
What do we know about the new obesity drug hitting the headlines? Find out what we know so far.
Are you ready to increase your step count? This 4 week walking plan will fast-track your walking and build you up to walking for 2 hours!
What are the benefits of walking? Discover how walking can improve your health and fitness.
Try these simple swaps and ways to boost your step count today to help improve your overall health and wellbeing by walking!
FAQs about walking for weight loss answered. Discover the calories burned from walking & motivational tips.
Weight Loss Drugs have hit the headlines recently with new clinical trials taking place on the drug 'Semaglutide' which was found to help participants lose up to 20% of their weight, but it is still not yet legally licensed in the UK.
